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derivatives derived from p‑bromo aniline moiety. The 
compounds synthesized were screened for anti‑inflammatory, 
antibacterial and antifungal activities.
MATERIALS AND METHODS
All the melting points were determined by open capillary 
method and were uncorrected. The final products were 
purified by recrystallization. The IR spectra were recorded 
by PERKIN ELMER FT‑IR Spectrophotometer using 
a thin film supported on KBr pellets.  1HNMR spectra 
were obtained in DMSO and chemical shift values are 
reported as values in ppm relative to TMS (δ = 0) as 
internal standard. Mass spectra were recorded on Jeol SX 
102/Da‑600 mass spectrometer.
Synthesis of ethyl-2-(4-bromophenylamino) acetate (I)
A mixture of p‑bromo aniline (13.9 g., 0.1 mol), 
ethylchloroacetate(12.25 ml, 0.1 mol) and anhydrous 
INTRODUCTION
Oxadiazoles are five‑membered heterocyclic compounds with 
two nitrogen and one oxygen atoms. They are synthesized 
by ring condensation and rearrangement reactions. Some 
of the recent studies have shown that 1,3,4‑oxadiazoles and 
its derivatives were reported to possess antimicrobial,[1] anti‑
inflammatory,[2] antibacterial,[3] anticancer,[4] antifungal,[5] 
tuberculostatic[6] and analgesic[7] activities. Moreover the 
amino compounds are very commonly used as antimicrobial 
and germicidal drug. By considering all the above factors, 
it was thought to synthesize some substituted oxadiazoles 
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potassium carbonate (19.5 g, 0.15 mol) in dry acetone 
was refluxed on a water bath for 24 hours at 70°C. The 
resultant reaction mixture was cooled and filtered. From 
the filtrate, excess of acetone was removed by distillation. 
The resultant solid was recrystallized from ethanol 
mp:150‑152°C;
IR(KBr) cm‑1:3374 (NH), 1720(C = O), 1600(C = C) 2851 
(CH),599 (C‑‑Br).
1H nmR(δ ppm): 7.16‑ 7.36 (4H, m,Ar),7.89 (1H,s,NH), 
4.2‑4.1 (2H,q,CH2), 3.85 (2H, s, CH2), 1.28‑1.24 (2H,t,CH3).
Synthesis of 2-(4-bromophenylamino) acetohydrazide (II)
A mixture of (I) (12.9 g.,0.05mol) and hydrazine hydrate 
(2.4 ml.,99%, 0.075mol) in ethanol (100 ml) was refluxed 
on a water bath for 6 hours. From the reaction mixture, 
excess of ethanol was removed by distillation. On 
cooling the resultant mixture, white needle like crystals 
of p‑bromo anilino aceto hydrazide began to separate. 
It was collected, filtered and recrystallized from ethanol 
mp:184‑186°C;
IR(KBr) cm−1:3374(NH str), 2902 (C‑H), 1640 (C = O), 
600(C‑‑Br).1HNMR(δ ppm): 9.5(1H,s,CONH), 8.5 
(1H,s,NH), 6.4‑7.1 (4H,m,Ar),4.2‑4.15 (2H,s,NH2), 3.84 
(2H,s,CH2).
Synthesis of 2-(4-bromophenylamino)-N’- (substituted 
benzylidene) acetohydrazide(IIIa-IIIj)
A mixture of (II) (0.01 mol) and different aromatic or 
heterocyclic aldehyde (0.01 mol) in ethanol was refluxed 
in presence of few drops of glacial acetic acid in a round 
bottom flask on a water bath for 6 hours. The reaction 
mixture was cooled and the solid thus separated was 
filtered, washed with ice cold water and recrystallized from 
ethanol. Table 1 enlists various substituents and Table 2 
summarizes physical data of the above compounds.
Synthesis of 4-bromo-N-((5-(substitutedphenyl)-1,3,4-
oxadiazol-2-yl)methyl)aniline:(IVa-IVj)
A solution of Schiff base (IIIa‑IIIj) (3.78 g.,0.01 mol(III b) 
in DMF (40 ml) was stirred in presence of yellow mercuric 
oxide (3 g) and iodine (1.5 g) at room temperature for 
48 hr under anhydrous conditions. The reaction mixture 
was filtered and poured onto crushed ice and stirred well. 
The solid thus separated out was washed with water and 
recrystallized from DMF::ethanol (1:1). Table 3 summarizes 
the physical data of these compounds.
IIId: 2-(4-Bromophenylamino)-N’-(4-
hydroxybenzylidene) acetohydrazide
IR (KBr) cm‑1: 3374OH str,3292(NH str), 3111 (C‑H 
str in CH2), 1668,(C = O) str in amide,1601(C = C str), 
502 (C‑‑Br str).1HNMR(δppm)9.82(1H,s,OH),9.78(1H,s, 
CONH),8.33(1H,s,NH),6.84‑7.9(9H,mAr and N=CH),3.8‑
3.9(2H,s,CH2).
Table 1: Various substituents in titled compounds 
(IVa‑IVj)
Compound R
IIIa/IVa
IIIb/IVb
IIIc/IVc
IIId/IVd
IIIe/IVe
IIIf/IVf
IIIg/IVg
IIIh/IVh
IIIi/IVi
IIIj/IVjBhat, et al.: Synthesis, characterization and biological activity studies of 1,3,4-oxadiazole analogs
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IVd:4-(5-((4-Bromophenylamino)methyl)-13,4-
oxadiazol-2-yl)phenol
IR (KBr) cm−1: 3398(NH)3269, (OH),1602(C=N), 
1589(C=C),1169 (C‑O‑C), 577 (C‑Br).1H nmR(δ ppm):
10.36(1H,s,OH), 8.9(1H,s,NH),6.8‑‑8.1(8H,m, Ar‑‑H), 2.59 
(2H,s,CH2) Mass in m/z: Molecular ion peak was observed 
at m/z 345.
IV g.4-Bromo-N-((5-(2-nitrophenyl)-1,3,4-oxadiazol-
2-yl)methyl)aniline
IR (KBr) cm‑1: 3359(NH str), 1615(C=N str),1579(C=C 
str), 1158(C‑O‑C str),531(C‑Br str)1 H nmR(δ ppm):
8.37(1H, s, NH), 6.7‑‑7.8(8H, m, Ar‑H), 2.33(2H, s, CH2) 
Mass in m/z: Molecular ion peak was observed at m/z 376.
IV h.4-Bromo-N-((5-(4-methoxy)--1,3,4-oxadiazol-2-
yl)methyl)aniline
IR (KBr) cm−1: 3289(NH str), 1600(C=N str),1596(C=C 
str), 1132(C‑O‑C str),562(C‑Br str)1 H nmR(δ ppm):
9.12(1H, s, NH),7.1‑7.9(8H, m, Ar‑‑H), 3.86 (3H,s, OCH3), 
2.56(2H, s, CH2) Mass in m/z: Molecular ion peak was 
observed at m/z 359.
RESULTS AND DISCUSSION
The main aim of this work was to synthesize 
various substituted 4‑bromo [(N‑5‑substituted 
[1,3,4 ‑oxadiazole‑2 –yl) methyl] aniline derivatives 
(Scheme 1). Initially N‑substituted benzylidines (IIIa‑IIIj) 
were synthesized by reacting p‑bromoaceto hydrazide (II) 
with substituted aromatic aldehyde in ethanol. The titled 
compounds (IVa‑IVj) were obtained by cyclization of 
N‑substituted benzylidine hydrazide in presence of iodine 
and mercuric oxide in DMF.
All the synthesized compounds resulted in good yields with 
50‑65%. The formation of title compounds (IVa‑IVj) is 
indicated by the disappearance of peak due to CH = N of 
the intermediate material Schiff base in IR and 1H‑NMR 
spectrum as given above. The IR of these compounds 
showed the presence of peaks due to (C=N and C‑O‑C) 
of the oxadiazole ring in all the compounds (IVa‑IVj). The 
mass spectra of the title compounds are in confirmative 
with the assigned structure. The mass spectrum of these 
compounds showed molecular ion peaks corresponding 
to their molecular formula [Table 3]. 
Among the newly synthesized compounds IVb, IVc, IVd 
and IVg showed good antifungal activity. The electron 
withdrawing groups like chlorine and electron releasing 
groups like methoxy and methyl (IVe, IVf, IVh) showed 
Table 2: Physical data of compounds (IIIa‑IIIj)
Compound Purification solvent Molecular formula Molecular weight Melting point (°C) % yield
IIIa Ethanol C13H12N3OSBr 339 224‑226 65
IIIb Ethanol C15H13N4O3Br 378 215‑217 60
IIIc Ethanol C15H14N3O2Br 349 230‑232 65
IIId Ethanol C15H14N3O3Br 349 210‑212 64
IIIe Ethanol C15H13N3OBrCl 365 225‑227 64
IIIf Ethanol C16H16N3OBr 345 200‑202 63
IIIg Ethanol C15H13N4O3Br 378 208‑210 58
IIIh Ethanol C16H16N3O2Br 363 190‑192 64
IIIi Ethanol C17H19N4OBr 376 205‑207 54
IIIj Ethanol C13H12N3O2Br 319 184‑186 63
Table 3: Physical data of compound (IVa‑IVj)
Compound Purification solvent Molecular formula Molecular weight Melting point (°C) % yield
IVa Ethanol:DMF (1:1) C13H12N3OSBr 335 204‑206 60
IVb Ethanol:DMF (1:1) C15H11N4O3Br 376 195‑200 56
IVc Ethanol:DMF (1:1) C15H12O2N3Br 345 240‑242 54
IVd Ethanol:DMF (1:1) C15H12N3O2Br 345 245‑247 60
IVe Ethanol:DMF (1:1) C15H11N3OBrCl 365 238‑239 59
IVf Ethanol:DMF (1:1) C16H14N3OBr 343 230‑232 62
IVg Ethanol:DMF (1:1) C15H11N4O3Br 376 235‑237 65
IVh Ethanol:DMF (1:1) C16H14N3O2Br 359 242‑244 58
IVi Ethanol:DMF (1:1) C17H18N4OBr 374 220‑222 51
IVj Ethanol:DMF (1:1) C13H10N3O2Br 319 216‑218 58Bhat, et al.: Synthesis, characterization and biological activity studies of 1,3,4-oxadiazole analogs
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better antibacterial activity. Compounds like IVa, IVd, 
IVf, IVg and IVj showed moderate anti‑inflammatory 
activity.
Biological evaluation
Antibacterial and antifungal activity
All the synthesized compounds were screened for their 
antibacterial activity[8] against Staphylococcus aureus (MTCC 
96), Bacillus subtilis, (MTCC 441), Pseudomonas aeruginosa 
(MTCC 1688) and Escherichia coli (MTCC 443) [strain no. 
indicating the source of  pure culture for all species used] using 
amoxicillin as standard drug. All the synthesized compound 
were also screened for their antifungal activity against 
Candida albicans (MTCC 227) and Aspergillus niger (MTCC 
282) using ketoconazole as standard drug. Compounds 
with substituents like – OH, – NO2, [IVb, IVc, IVd, IVg] 
showed moderate antifungal activity. Compounds with 
substituents like p‑OCH3, p‑Cl, p‑CH3, [IVe, IVf, IVh] 
showed better antibacterial activity. Data of antimicrobial 
activity is summarized in Table 4.
Anti-inflammatory activity by Carrageenan-induced 
rat hind paw edema method
Group I (Control) Vehicle (p.o)
Group II (Standard) Diclofenac 13.5mg/ kg body 
weight (p.o)
Group III to XII (Test) 40 mg/kg body weight (oral) of 
1, 3, 4 oxadiazole derivatives in 
0.6 %w/v DMSO
Animals were divided into 12 different groups contained six 
in each group. After 30 minutes of administration of standard 
and test compounds an inflammatory edema was induced in 
the left hind paw by injection of 0.1 ml of 1% of carrageenan 
solution in the plantar tissue of the paw of all the animals. 
The initial paw volume was measured plethysmographically 
(IITC digital plethysmograph, IITC‑520) within 30 second 
of the injection. The relative increase in paw volume was 
measured in control, standard and test groups at 1, 2, 3 and 
4‑hour intervals after carrageenan injection.[9]
The percentage inhibition of edema volume was calculated 
by using the formula
Percentage inhibition=1
V
V
×100
t
c
−

 

 
Where Vt and VC are the relative change in the edema 
volume of paw after the administration of the test and 
control, respectively. Data of anti‑inflammatory activity is 
summarized in Table 5.
Statistical analysis
All the values were expressed as mean ± SEM using One‑
way ANOVA followed by Dunnet’s —t test.
CONCLUSION
The 1,3,4 oxadiazole derivatives reported showed good 
Scheme 1: (III a‑j)  2‑(4‑bromophenylamino)‑N’‑ (substituted 
benzylidene) acetohydrazide (IVa‑j) 4‑bromo‑N‑((5‑(substituted 
phenyl)‑1,3,4‑oxadiazol‑2‑yl)methyl)aniline
Table 4: Antimicrobial activity of titled compounds 
(IVa‑IVj)
Compound Diameter of zone of inhibition (mm)
S. aureus B. subtilis E. coli P. aeruginosa C. albicans
IVa 13 15 14 13 08
IVb 14 14 13 12 15
IVc 14 15 14 15 14
IVd 15 14 13 13 15
IVe 18 19 18 15 08
IVf 19 17 18 16 09
IVg 14 12 15 10 15
IVh 18 18 19 15 09
IVi 16 15 14 13 10
IVj 15 14 15 12 11
Amoxicillin 21 22 21 22 ‑
Ketoconazole ‑ ‑ ‑ ‑ 23Bhat, et al.: Synthesis, characterization and biological activity studies of 1,3,4-oxadiazole analogs
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antimicrobial and anti‑inflammatory activities. Derivatives 
IVb, IVc, IVd, IVg showed moderate antifungal activity. 
Compounds IVe, IVf, IVh, respectively, showed better 
antibacterial activity, whereas all the compounds showed 
good anti‑inflammatory activity.
ACKNOWLEDGMENT
The authors are thankful to Nitte University, Deralakatte, Mangalore, 
India, for providing necessary facilities and also to SAIF‑Punjab 
University, CDRI Lucknow for providing spectral data.
REFERENCES
1.  Ingole SP, Mohane SR, Berad BN. Synthesis and antimicrobial activity 
of 2‑alkyl –aryl ‑5‑(Pyrid‑4‑yl)‑1,3,4‑oxadiazole. Asian J Chem 
2007;19:2683‑6.
2.  Amir M, Javed SA, Kumar H. Synthesis of some 1,3,4oxadiazole derivatives 
as potential anti‑inflammatory agents. Indian J Chem 2007;46B:1014‑9.
3.  Siddiqui N, Khan SA, Bhat MA. Synthesis and antibacterial activity 
of coumarin incorporated 1,3,4oxadiazoles. Indian J Het Chem 2005; 
14:271‑2.
4.  Shivarama Holla B, Poojary KN, Subrahmanya Bhat K, Ashok M, Poojary B. 
Synthesis and anticancer activity studies on some 2‑Chloro‑1, 4‑bis‑
(‑substituted‑1, 3, 4‑oxadiazole‑2‑ylmethyl enoxy) phenylene derivatives. 
Indian J Chem 2005;44B:1669‑73.
5.  Mishra A, Singh DV, Mishra RM. Synthesis, antifungal activity of 
new1,3,4oxadiazole(3,2‑b)‑s‑triazine‑5‑ones and their thiones analogues. 
Indian J Het Chem 2005;14:289‑92.
6.  Franski R. Biological activities of the compounds bearing 1,3,4‑oxa(thia) 
diazole ring. Asian J Chem 2005;17:2063‑75.
7.  Reddy VM, Reddy PS, Reddy PC, Ratmanc V. Cyclisation by 
dehydrosulfuration of 1‑(2‑amino benzoyl) ‑4‑aryl‑3 thiosemicarbazides. 
Formation of 1,3,4benzotriazepinones, 1,3,4 thiadiazoles and 1,3,4 
oxadiazoles. Indian J Het Chem 1997;7:17‑20.
8.  Satyanarayana D, George S, Subrahmanyam EVS, Kalluraya B. Studied 
the biological activity of 5‑pyridyl‑ 3‑arylaminomethyl‑1, 3, 4‑oxadiazol‑2 
thiones. Indian J Het Chem 1997;11:189‑92.
9.   Winter CA, Risely EA, Nuss EV. Carrageenin induced oedema in hint paw 
of the rats as an assay for anti‑inflammatory drugs. Proc Soc Exp Biol Med 
1962;111:544‑7.
Table 5: Anti‑inflammatory activity of titled compounds (IVa‑IVj)
Treatment Dose mg/kg Increase in paw volume (in ml)
1h 2h 3h 4h
Control _ 0.36 ± 0.06 0.68 ± 0.05 0.77 ± 0.03 0.81 ± 0.03
Diclofenac 
Sodium
13.5 0.18 ± 0.03*
(50)
0.35 ± 0.05*
(48.52)
0.41 ± 0.04*
(46.75)
0.45 ± 0.05*
(44.44)
IVa 40 0.20 ± 0.03*
(44.44)
0.37 ± 0.03*
(45.58)
0.42 ± 0.03*
(45.45)
0.46 ± 0.03*
(43.20)
IVb 40 0.23 ± 0.04
(36.11)
0.41 ± 0.04
(39.70)
0.47 ± 0.04
(38.96)
0.52 ± 0.04
(35.80)
IVc 40 0.24 ± 0.03
(33.33)
0.42 ± 0.02
(38.23)
0.46 ± 0.03
(40.25)
0.52 ± 0.03
(35.80)
IVd 40 0.19 ± 0.04*
(47.22)
0.37 ± 0.03*
(45.58)
0.42 ± 0.03*
(45.45)
0.46 ± 0.04*
(43.20)
IVe 40 0.19 ± 0.04*
(47.22)
0.36 ± 0.03*
(47.05)
0.41 ± 0.03*
(46.75)
0.48 ± 0.03*
(40.74)
IVf 40 0.20 ± 0.03*
(44.44)
0.37 ± 0.03*
(45.58)
0.42 ± 0.03*
(45.45)
0.46 ± 0.03*
(43.20)
IVg 40 0.23 ± 0.04*
(47.22)
0.36 ± 0.03*
(47.05)
0.45 ± 0.03*
(46.75)
0.47 ± 0.03*
(40.74)
IVh 40 0.16 ± 0.04
(17.77)
0.43 ± 0.04
(36.76)
0.50 ± 0.04
(35.06)
0.56 ± 0.03
(30.86)
IVi 40 0.23 ± 0.03
(36.11)
0.40 ± 0.03
(41.17)
0.47 ± 0.03
(38.96)
0.51 ± 0.04
(37.03)
IVj 40 0.22 ± 0.06
(38.88)
0.38 ± 0.03
(44.11)
0.45 ± 0.02
(41.55)
0.48 ± 0.04*
(40.74)
All values are expressed as mean±SEM (n=6) *P<0.05 significant compared to control
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